Clinical trials can be a lifeline for patients with cancer, providing leading-edge care by clinicians dedicated to a specific disease, and the oncology community is filled with stories of patients whose lives were improved and/or extended due to participation in a trial. Despite the potential of clinical research to improve outcomes for patients with cancer, enrollment in trials remains stubbornly low—fewer than 3% of cancer patients in the U.S. participate.1According to a review of 7,776 adult oncology trials between 2005 and 2011, 20% closed early due to failure to meet their enrollment targets.2
The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships.
The ACORI Call to Action Summit: Activating Equity in Community Oncology Research—in collaboration with Stand Up to Cancer—identified concrete strategies for engaging patients, caregivers, and their communities to strengthen oncology research. More than 120 people from 60 organizations generated 200+ ideas for action items to make cancer care research more diverse, equitable, and accessible.
Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinking—solutions to help this population better access clinical trials, including a tool from the Leukemia and Lymphoma Society to help patients identify cancer clinical trials that may be a fit.
In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so.
In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.
Learn about the latest promising breakthroughs in immunotherapy, the challenges facing their widespread use, and what your cancer team needs to know about the future of cancer treatment.
Learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioritized community engagement.
We explore how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials.
Discover the results of the 2019 Trending Now in Cancer Care Survey—what tops the list of challenges, what areas are trending towards growth, and how cancer programs are evolving to meet the demands of 21st-century cancer care delivery.
Learn how a rural health system harnessed its passion and creativity to work around obstacles to clinical trial access and ensure its patients have access to cutting-edge cancer treatments.
An online implicit bias training program that presents the broader context of structural and systemic racism, the role of implicit bias in clinical trial selection, vignettes with real-world examples of implicit bias, and guidance for mitigating disparities in cancer research settings.
To facilitate fruitful discussions with staff around implicit bias, this Just Ask™ Training Facilitation Guide has been developed to identify feasible action steps to support implementation of a Just Ask™ strategy in your research site or cancer program or practice.
The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.
(Sep 13-14, 2021)
An expert panel reviews currently available data on cancer care disparities, discusses the needs of disadvantaged populations, and shares practical solutions and methods for implementing bias training. (April 20, 2021)
An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic.
Optimal care delivery changes from place to place—what works best for one location and patient population may not be ideal for another. The same applies to cancer research. Understanding the needs of your patient population is critical to trial design and implementation. How can you proactively involve your community in cancer research activities? (January 27, 2021)
Key issues in high integrity tissue acquisition facing community cancer programs. (December 17, 2020)
Key results from a recent nationwide survey on the role of APs in cancer clinical research. (November 2, 2020)
Learn more about resources which already exist, successful models for pharmacist integration into oncology research teams, and the unique skills which pharmacists offer the interdisciplinary team. (October 30, 2020)
Join Nadine J. Barrett as she details strategies to improve clinical trial accrual for racial and ethnic minorities, as well as other at-risk groups. (July 24, 2020)
Diversify Your Cancer Clinical Trials with New Recruitment and Retention Resources
ACCC, Jul 25, 2022
Providing More Equitable Care in Clinical Trials: Oncologists Reflect Over Black History Month
Cancer Network, Feb 28, 2022
Advanced Practice Providers Are Poised to Boost Community Involvement in Clinical Trials
OncLive, July 19, 2021
Association of Community Cancer Centers Launches Institute to Diversify Cancer Clinical Trials
June 2, 2021